During the past decade, Community Cancer Center at Rutland Regional Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Community Cancer Center at Rutland Regional Medical Center" #1 sponsor was "Radiation Therapy Oncology Group" with 6 trials, followed by "NSABP Foundation Inc" with 2 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "Tragara Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Community Cancer Center at Rutland Regional Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 10 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "American College of Surgeons" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Cancer and Leukemia Group B" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Community Cancer Center at Rutland Regional Medical Center" are "Breast Cancer" (5 trials), "Prostate Cancer" (2 trials), "Brain and Central Nervous System Tumors" (1 trials), "Cachexia" (1 trials) and "Head and Neck Cancer" (1 trials). Many other conditions were trialed in "Community Cancer Center at Rutland Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Community Cancer Center at Rutland Regional Medical Center" are "Drug" (9 trials), "Radiation" (6 trials), "Dietary Supplement" (2 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (3 trials), "adjuvant therapy" (2 trials), "tamoxifen citrate" (2 trials), "Bevacizumab" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Community Cancer Center at Rutland Regional Medical Center" are 5 trials for "Female" genders, 4 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Community Cancer Center at Rutland Regional Medical Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Community Cancer Center at Rutland Regional Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Community Cancer Center at Rutland Regional Medical Center, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".